Overview
KRYS market data
Price History
KRYS price chart · 1M
- O
- 365.44
- H
- 365.44
- L
- 353.98
- C
- 358.19
- Vol
- 19,372.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $365.44
- Previous Close
- $371.25
- Day High
- $365.44
- Day Low
- $353.98
- 52 Week High
- $382.01
- 52 Week Low
- $242.00
- 7 Day Return
- +1.87%
- 30 Day Return
- +9.99%
- 90 Day Return
- +18.64%
- 1 Year Return
- +39.74%
- Daily Notional Volume
- $6.9M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 45.11 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $6.84 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.54 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 54.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $136.73 – $382.54 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $10.9B · P/B 5.86 · P/S 24.73.
Company News
10 captured
Krystal Biotech to Present at 2026 Cantor Global Healthcare ConferenceGlobenewswire Inc ·
Krystal Biotech shares are trading lower after the company announced mixed Q2 financial results.Benzinga ·
8-K filing — Krystal Biotech, Inc. (KRYS)SEC EDGAR ·
Krystal Biotech Q2 EPS $1.79 Beats $1.66 Estimate, Sales $119.222M Miss $121.061M EstimateBenzinga ·
Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026Globenewswire Inc ·
Why Tutor Perini Stock Trounced the Market on TuesdayThe Motley Fool ·